PBMs Come Under Fire During Senate Hearing

PBMs Come Under Fire During Senate Hearing

Pharmacy Benefit Managers (PBMs) took a hit from lawmakers during a Thursday hearing held by the Senate Commerce Committee, with some questioning why the drug middlemen are even necessary.
“The way I see the situation on PBMs, I don’t know why the hell they even exist,” said Sen. Jon Tester, D-Montana. “They were set up with all the right reasons … But what I see them doing in my state, I don’t think the consumer gets much benefit and they’re shutting down small businesses on main street right and left and those are called our local neighborhood pharmacies.” The hearing discussed how…

Continue Reading
Is Interoperability Tech Worth the Investment? Experts Say Yes for 3 Reasons

Is Interoperability Tech Worth the Investment? Experts Say Yes for 3 Reasons

Editor’s note: This story is based on discussions at Abarca Forward, a conference in San Juan, Puerto Rico, hosted by Abarca, a pharmacy benefit manager. MedCity News’ Editor-in-Chief Arundhati Parmar and Senior Reporter Katie Adams were invited to attend and speak at the conference. All travel and related expenses for the team were covered by Abarca. However, company officials had no input in editorial coverage. 
In order for the U.S. healthcare system to operate smoothly, various stakeholders must cooperate with one another and share data seamlessly. But this notion is far from being achieved — the industry is still seriously plagued by…

Continue Reading
The Federal Trade Commission Accuses GoodRx Of Multiple Data Sharing Fails, Demands It Pay $1.5 Million Fine and Make Reforms

The Federal Trade Commission Accuses GoodRx Of Multiple Data Sharing Fails, Demands It Pay $1.5 Million Fine and Make Reforms

The Federal Trade Commission has cited telehealth and prescription drug discount provider GoodRx for sharing sensitive consumer health data with several advertising platforms, in violation of its own privacy promises to consumers.
The agency has filed a proposed order demanding that GoodRx pay $1.5 million in civil penalties for failing to let consumers know about unauthorized disclosures of its data to a list of advertiser platforms. including Facebook and Google.
The company, which is based in California, operates a digital health platform offering prescription drug discounts, telehealth visits and other health services. It captures a wide range of data from consumers who use…

Continue Reading